Advertisement

#GI20

Conferences

Three-Drug Immunotherapy Combo Shrinks Liver Tumors

A triple regimen of Opdivo, Yervoy and Cabometyx showed good activity, but side effects may limit its use.

Should People With NAFLD or NASH Be Monitored for Liver Cancer?

Those with fatty liver disease and cirrhosis should undergo regular screening.

Vitrakvi Shows Good Results for Gastrointestinal Cancers

TRK inhibitor larotrectinib led to durable responses in people with colon, pancreatic, appendix, bile duct and liver cancers.

Immunotherapy Combo Improves Quality of Life for People With Liver Cancer

Tecentriq plus Avastin improved improved overall survival and patient experiences during treatment.

Digestive system

Blood Test Boasts High Accuracy in ID’ing Gastrointestinal Cancers

Many people with GI cancers are diagnosed only after the disease has spread through the body, so this test could aid in early detection.

Advertisement